HCRx - About the company
HCRx is an acquired company based in Stamford (United States), founded in 2007 by Dennis Lanfear. It operates as a R&D company focused on manufacturing drugs for multiple therapeutic areas.
Company Details
- Website
- www.hcrx.com/
- Email ID
- *****@hcrx.com
- Phone Number
- +1 **********
Key Metrics
Founded Year
2007
Location
Stamford, United States
Stage
Acquired
Employee Count
31 as on Jun 30, 2026
Investment & Acquisitions
Exit Details
Acquired by KKR (Jul 30, 2025)
HCRx's acquisition details
HCRx got acquired by KKR on Jul 30, 2025.
Click here to take a look at HCRx's acquisition in detail
Sign up to download HCRx's company profile
HCRx's funding and investors
HCRx has not raised any funding rounds yet.
HCRx's founders and board of directors
Founder? Claim ProfileThe founders of HCRx is Dennis Lanfear.
Here are the details of HCRx's key team members:
- Dennis Lanfear: Founder & Managing Partner of HCRx.
View details of HCRx's Founder profiles and Board Members
HCRx's employee count trend
HCRx has 31 employees as of Jun 26. Here is HCRx's employee count trend over the years:
Uncover HCRx's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
HCRx's Investments and acquisitions
HCRx has a total of 1 investment in Apnimed. HCRx has not made any acquisitions as of now.Reports related to HCRx
Here is the latest report on HCRx's sector:
News related to HCRx
Filter this listMedia has covered HCRx for a total of 10 events in the last 1 year, 2 of them have been about company updates.
•
Spero Therapeutics Secures $105 Million Non-Dilutive Financing for Immunology Drug DevelopmentGlobeNewswire•Jul 14, 2026•HCRx, Spero Therapeutics
•
BridgeBio Raises $1 Billion in Preferred Equity to Accelerate Present and Upcoming LaunchesAktiencheck•Jul 01, 2026•BridgeBio, Sixth Street, HCRx, KKR
•
•
Heidelberg Pharma Receives $20M Funding via Amended Royalty AgreementWebDisclosure•Mar 09, 2026•Heidelberg Pharma, Soleus Capital, Telix Pharma, HCRx and 1 other
•
ADC Therapeutics Amends HealthCare Royalty Financing AgreementPR Newswire•Feb 23, 2026•HCRx, ADC Therapeutics
•
•
KKR Acquires Healthcare Royalty Partners to Expand Life Sciences InvestmentEndpoints•Jul 30, 2025•HCRx, KKR, Debevoise and Plimpton
•
Liquidia Receives $50 Million From Healthcare Royalty After YUTREPIA™ First SaleGlobeNewswire•Jun 24, 2025•Liquidia, HCRx
•
REGENXBIO Announces $250 Million Royalty Monetization AgreementPR Newswire•May 20, 2025•Regenxbio, HCRx, Covington & Burling, Morgan Lewis
•
REGENXBIO announces royalty monetization agreement for up to $250MSeeking Alpha•May 19, 2025•Regenxbio, HCRx
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about HCRx
Explore our recently published companies
- Salmonandsable - Unfunded company
- Order Asprigofthymesrq - Unfunded company
- Pizzatupwalthamabbey - United Kingdom based, Unfunded company
- Damascusbakeryandsweets - United Kingdom based, Unfunded company
- Alifishandchips - United Kingdom based, Unfunded company
- Pasam Pizza Kebab - Germany based, Unfunded company
